Cancer-associated retinopathy (CAR) is a paraneoplastic syndrome most often
associated with small-cell lung carcinoma (SCLC), and it has been reported
in patients with other malignancies. Antibodies against recoverin, a 23-kD
a protein, have been found in patients with CAR suggesting an autoimmune ph
enomenon. Herein is the first report of a patient with non-small-cell lung
cancer (NSCLC) in whom anti-recoverin antibodies were detected in the serum
. Steroid therapy, chemotherapy, and radiation therapy did not help the pat
ient's vision. Progressive loss of vision in patients with lung cancer shou
ld, potentially, be tested for CAR. (C) 1998 Elsevier Science Ireland Ltd.
All rights reserved.